Загрузка...
Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a randomized controlled trial
In postmenopausal women, 2-years of combined teriparatide and denosumab increases bone mineral density (BMD) more than either drug alone and switching from either combination or teriparatide to denosumab for an additional 2-years further increases BMD. Conversely switching from denosumab to teripara...
Сохранить в:
| Опубликовано в: : | J Clin Densitom |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5673584/ https://ncbi.nlm.nih.gov/pubmed/28624340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jocd.2017.05.007 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|